ENVEDA BIOSCIENCES
Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle todayโs biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is based in San Francisco, California.
ENVEDA BIOSCIENCES
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.envedabio.com
Total Employee:
11+
Status:
Active
Contact:
+1-415-323-5252
Email Addresses:
[email protected]
Total Funding:
55.9 M USD
Technology used in webpage:
Domain Not Resolving Amazon IPv6 Google Apple Mobile Web App Capable Amazon Route 53 Amazon S3 Apple Mobile Web App Status Bar Style Amazon SSL Amazon CloudFront
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Employees Featured
Founder
Investors List
Village Global
Village Global investment in Series A - Enveda Biosciences
Two Sigma Ventures
Two Sigma Ventures investment in Series A - Enveda Biosciences
Lifeforce Capital
Lifeforce Capital investment in Series A - Enveda Biosciences
Lux Capital
Lux Capital investment in Series A - Enveda Biosciences
Chris Gibson
Chris Gibson investment in Series A - Enveda Biosciences
Hummingbird Ventures
Hummingbird Ventures investment in Series A - Enveda Biosciences
True Ventures
True Ventures investment in Series A - Enveda Biosciences
Wireframe Ventures
Wireframe Ventures investment in Series A - Enveda Biosciences
Catalio Capital Management
Catalio Capital Management investment in Series A - Enveda Biosciences
Matthew De Silva
Matthew De Silva investment in Series A - Enveda Biosciences
Key Employee Changes
Official Site Inspections
http://www.envedabio.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.62 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013